Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

1.5K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

7.7K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterizing the microbiota of traditional wooden tools and their impact on the hygiene and quality of TAP Vastedda Palermitana cheese.

International journal of food microbiology·2026
Same author

Beyond Inflammation: The Role of Oxidative Stress and Gut-Skin Axis Dysbiosis in the Pathogenesis of Immune-Mediated Skin Disorders and Potential Therapeutic Implications.

International journal of molecular sciences·2026
Same author

<i>Passiflora edulis</i> Sims. cultivated in Sicily: chemical profile, antioxidant activity and antimicrobial potential of its passion fruit.

Natural product research·2026
Same author

Artificial intelligence in allergen immunotherapy: toward a proactive and personalized management of allergic diseases.

Current opinion in allergy and clinical immunology·2026
Same author

Could belimumab be a new weapon in autoimmune complicated CVID?

Frontiers in immunology·2026
Same author

Allergic Anisakiasis: An Integrated Review of Human, Animal and Cellular Evidence.

Biomolecules·2026
Same journal

Correction: Reis et al. Bioinks Enriched with ECM Components Obtained by Supercritical Extraction. <i>Biomolecules</i> 2022, <i>12</i>, 394.

Biomolecules·2026
Same journal

Correction: Kim, K.-H.; Yoo, B.C. Gintonin as a Lysophosphatidic Acid-Enriched GPCR Ligand System: Molecular Architecture and Receptor Pharmacology in <i>Panax ginseng</i>. <i>Biomolecules</i> 2026, <i>16</i>, 465.

Biomolecules·2026
Same journal

Correction: Bastyte et al. The Association of Vitamin D Receptor Gene Polymorphisms with Vitamin D, Total IgE, and Blood Eosinophils in Patients with Atopy. <i>Biomolecules</i> 2024, <i>14</i>, 212.

Biomolecules·2026
Same journal

AtHSPR Plays a Positive Role in Arabidopsis Resistance Against <i>Pseudomonas syringae</i> pv. <i>tomato</i> DC3000 by Interacting with TOP1.

Biomolecules·2026
Same journal

CYTH4 Facilitates Renal Cell Carcinoma via Enhancing Proliferation and Likely Immune Evasion.

Biomolecules·2026
Same journal

Integrated Immune-Gut Profiling Identifies an Exploratory Pediatric Inflammatory Intestinal Profile Associated with Food-Specific IgG Reactivity.

Biomolecules·2026
See all related articles

Related Experiment Video

Updated: Oct 6, 2025

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
12:19

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks

Published on: November 10, 2016

8.4K

HMGB-1 in Psoriasis.

Marco Casciaro1, Eleonora Di Salvo2, Sebastiano Gangemi1

  • 1School and Unit of Allergy and Clinical Immunology, Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy.

Biomolecules
|January 21, 2022
PubMed
Summary
This summary is machine-generated.

High mobility group box 1 (HMGB1) levels are elevated in psoriasis patients, contributing to systemic inflammation. Blocking HMGB1 shows promise as a therapeutic strategy for psoriasis and other immune-related diseases.

Keywords:
HMGB-1alarminbiologicimmune systeminflammationmonoclonalpsoriasisskintherapy

More Related Videos

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.1K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.3K

Related Experiment Videos

Last Updated: Oct 6, 2025

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks
12:19

Tools to Study the Role of Architectural Protein HMGB1 in the Processing of Helix Distorting, Site-specific DNA Interstrand Crosslinks

Published on: November 10, 2016

8.4K
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

39.1K
Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

6.3K

Area of Science:

  • Immunology
  • Dermatology
  • Molecular Biology

Background:

  • Psoriasis is a chronic inflammatory skin condition characterized by enhanced keratinocyte proliferation and immune cell infiltration.
  • Systemic inflammation and dysregulation of apoptosis are key features of psoriasis.
  • High mobility group box 1 (HMGB1), an alarmin released during cellular damage, plays a role in inflammatory conditions.

Purpose of the Study:

  • To evaluate HMGB1 levels in psoriasis patients.
  • To investigate the potential of blocking HMGB1 as a therapeutic strategy for psoriasis.
  • To correlate HMGB1 levels with disease severity and other inflammatory markers.

Main Methods:

  • Measurement of HMGB1 levels in lesional skin and serum of psoriasis patients.
  • Assessment of correlation between HMGB1 levels, other pro-inflammatory markers, alarmins, and the Psoriasis Area and Severity Index (PASI) score.
  • Evaluation of the efficacy of HMGB1 blockade through standard therapies, biological treatments, and monoclonal antibodies.

Main Results:

  • Psoriasis patients exhibited significantly increased levels of HMGB1 in both lesional skin and serum.
  • Elevated HMGB1 levels were often linked to other pro-inflammatory markers and alarmins.
  • In most cases, these parameters correlated with the PASI score, indicating disease severity.
  • Blocking HMGB1 demonstrated effectiveness in ameliorating psoriasis symptoms.

Conclusions:

  • HMGB1 is a significant factor in psoriasis pathogenesis, acting as an alarmin that exacerbates inflammation.
  • Targeting HMGB1 through blockade therapies presents a promising therapeutic avenue for psoriasis.
  • HMGB1 blockade offers a novel approach for managing immune-related diseases, expanding therapeutic possibilities.